FN Thomson Reuters Web of Knowledge
VR 1.0
PT J
AU Hao, HF
   Takaoka, M
   Bao, XH
   Wang, ZG
   Tomono, Y
   Sakurama, K
   Ohara, T
   Fukazawa, T
   Yamatsuji, T
   Fujiwara, T
   Naomoto, Y
AF Hao, Hui-fang
   Takaoka, Munenori
   Bao, Xiao-hong
   Wang, Zhi-gang
   Tomono, Yasuko
   Sakurama, Kazufumi
   Ohara, Toshiaki
   Fukazawa, Takuya
   Yamatsuji, Tomoki
   Fujiwara, Toshiyoshi
   Naomoto, Yoshio
TI Oral administration of FAK inhibitor TAE226 inhibits the progression of
   peritoneal dissemination of colorectal cancer
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Focal adhesion kinase; TAE226; Peritoneal dissemination; Prolonged
   survival; Anti-proliferation; Colon cancer
ID FOCAL ADHESION KINASE; IN-VIVO; GROWTH; CARCINOMA; VITRO
AB Peritoneal dissemination is one of the most terrible types of colorectal cancer progression. Focal adhesion kinase (FAK) plays a crucial role in the biological processes of cancer, such as cell attachment, migration, proliferation and survival, all of which are essential for the progression of peritoneal dissemination. Since we and other groups have reported that the inhibition of FAK activity exhibited a potent anticancer effect in several cancer models, we hypothesized that TAE226, a novel ATP-competitive tyrosine kinase inhibitor designed to target FAK, can prevent the occurrence and progression of peritoneal dissemination. In vitro, TAE226 greatly inhibited the proliferation and migration of HCT116 colon cancer cells, while their adhesion on the matrix surface was minimally inhibited when FAK activity and expression was suppressed by TAE226 and siRNA. In vivo, when HCT116 cells were intraperitoneally inoculated in mice, the cells could attach to the peritoneum and begin to grow within 24 h regardless of the pretreatment of cells with TAE226 or FAK-siRNA, suggesting that FAK is not essential, at least for the initial integrin-matrix contact. Interestingly, the treatment of mice before and after inoculation significantly suppressed cell attachment to the peritoneum. Furthermore, oral administration of TAE226 greatly reduced the size of disseminated tumors and prolonged survival in tumor-bearing mice. Taken together, a possible strategy for inhibiting peritoneal dissemination by targeting FAK with TAE226 appears to be applicable through anti-proliferative and anti-invasion/anti-migration mechanisms. (C) 2012 Elsevier Inc. All rights reserved.
C1 Kawasaki Med Univ, Dept Gen Surg, Kita Ku, Okayama 7008505, Japan.
   Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg Gastroenterol, Kita Ku, Okayama 7008558, Japan.
   Inner Mongolia Univ, Coll Life Sci, Key Lab Mammal Reprod Biol & Biotechnol, Minist Educ, Hohhot 010021, Peoples R China.
   Shigei Med Res Inst, Div Mol & Cell Biol, Okayama 7000202, Japan.
RP Naomoto, Y (reprint author), Kawasaki Med Univ, Dept Gen Surg, Kita Ku, 2-1-80 Nakasange, Okayama 7008505, Japan.
EM ynaomoto@med.kawasaki-m.ac.jp
CR Deramaudt TB, 2006, MOL CELL BIOL, V26, P4185, DOI 10.1128/MCB.01055-05
   Franses JW, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001542
   Golubovskaya VM, 2008, MOL CARCINOGEN, V47, P222, DOI 10.1002/mc.20380
   Golubovskaya VM, 2010, ANTI-CANCER AGENT ME, V10, P735
   Golubovskaya VM, 2009, HISTOL HISTOPATHOL, V24, P503
   Halder J, 2007, CANCER RES, V67, P10976, DOI 10.1158/0008-5472.CAN-07-2667
   Hashimoto K, 2005, CANCER RES, V65, P540
   Ilic Dusko, 1995, Nature (London), V377, P539
   Lawson C, 2012, J CELL BIOL, V196, P223, DOI 10.1083/jcb.201108078
   Liu TJ, 2007, MOL CANCER THER, V6, P1357, DOI 10.1158/1535-7163.MCT-06-0476
   Mima H, 2006, MOL CANCER THER, V5, P1021, DOI 10.1158/1535-7163.MCT-05-0352
   Murata T, 2008, INT J ONCOL, V32, P791
   OWENS LV, 1995, CANCER RES, V55, P2752
   Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957
   Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373
   Sakurama K, 2009, MOL CANCER THER, V8, P127, DOI 10.1158/1535-7163.MCT-08-0884
   Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9
   Shi Q, 2007, MOL CARCINOGEN, V46, P488, DOI 10.1002/mc.20297
   Shieh AC, 2011, CANCER RES, V71, P790, DOI 10.1158/0008-5472.CAN-10-1513
   Watanabe N, 2008, CLIN CANCER RES, V14, P4631, DOI 10.1158/1078-0432.CCR-07-4755
   Yonemura Y, 2007, CANCER SCI, V98, P11, DOI 10.1111/j.1349-7006.2006.00350.x
NR 21
TC 0
Z9 0
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JUL 13
PY 2012
VL 423
IS 4
BP 744
EP 749
DI 10.1016/j.bbrc.2012.06.030
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 982GZ
UT WOS:000307032400022
ER

PT J
AU Mochizuki, A
   Kimura, M
   Ina, A
   Tomono, Y
   Tanaka, M
AF Mochizuki, Akira
   Kimura, Maki
   Ina, Ayano
   Tomono, Yuka
   Tanaka, Masaru
TI Study on the Water Structure and Blood Compatibility of
   Poly(acryloylmorpholine-r-butyl methacrylate)
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Water structure; bound water; blood compatibility; platelets;
   coagulation system; DSC; N-substituted acrylamide co-polymer
ID SELF-ASSEMBLED MONOLAYERS; PROTEIN ADSORPTION; PLATELET-ADHESION;
   SURFACE; BIOMATERIAL; GLYCOL); PLASMA
AB We have been studying the blood compatibility of polymeric materials from the viewpoint of their water structure, and have proposed that freezable water interacting with polymer molecules plays an important role in determining that compatibility. As we found that water-soluble poly(acryloylmorpholine) interacted with water, resulting in the formation of 'bound water', we newly prepared water-non-soluble poly(acryloylmorpholine-r-butyl methacrylate) (denoted as ACMO co-polymer) with various composition ratios. In addition, the properties of a co-polymer based on N,N-diethylacrylamide (DEA co-polymer), where DEA has a similar chemical structure to ACMO, except that DEA has no ether oxygen, were compared with that of the ACMO co-polymer. Contact angle and DSC analysis revealed that an increase in the content of an N-substituted acrylamide unit in the co-polymers enhanced the hydrophilicity of the polymer and that the hydrophilicity of the ACMO co-polymer was stronger than that of the DEA co-polymer. As for the water structure, it was found that the ACMO co-polymer had a lot of bound water compared to the DEA co-polymer. The difference in these properties between the ACMO and DEA co-polymers was due to the ether oxygen of the morpholine group. At the same time, in vitro blood compatibility tests showed that the ACMO co-polymer exhibited a much better performance than the DEA co-polymer. The water structure and blood compatibility is discussed in detail. (C) Koninklijke Brill NV, Leiden, 2010
C1 Tokai Univ, Dept Biomed Engn, Sch High Technol Human Welf, Shizuoka 4100395, Japan.
   Yamagata Univ, Dept Biochem Engn, Grad Sch Sci & Engn, Yamagata 9928510, Japan.
RP Mochizuki, A (reprint author), Tokai Univ, Dept Biomed Engn, Sch High Technol Human Welf, Nishino 317, Shizuoka 4100395, Japan.
EM azmochi@wing.ncc.u-tokai.ac.jp
CR Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   ANDRADE JD, 1973, T AM SOC ART INT ORG, V19, P1
   Benesch J, 2001, J BIOMAT SCI-POLYM E, V12, P581, DOI 10.1163/156856201316883421
   CAZENAVE JP, 1986, BLOOD SURFACE INTERA
   Chuang WH, 2007, J BIOMED MATER RES A, V82A, P820, DOI 10.1002/jbm.a.31193
   Chung YC, 2005, BIOMATERIALS, V26, P2313, DOI 10.1016/j.biomaterials.2004.06.043
   GLASSER WG, 1992, ACS S SERIES, V489
   GOLBET MB, 2004, BIOMATERIALS, V22, P5681
   GRIFFIN JH, 2006, WILLIAMS HEMATOLOGY, P1703
   Hansson KM, 2005, BIOMATERIALS, V26, P861, DOI 10.1016/j.biomaterials.2004.03.036
   Hirota E, 2006, J BIOMED MATER RES A, V76A, P540, DOI 10.1002/jbm.a.30563
   Hirota E, 2007, J BIOMED MATER RES A, V81A, P710, DOI 10.1002/jbm.a.31113
   Ide M, 2003, LANGMUIR, V19, P429, DOI 10.1021/1a020617p
   Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   MIWA Y, 2003, J JPN SOC BIOMATER, V21, P143
   Morita S, 2007, LANGMUIR, V23, P3750, DOI 10.1021/la0625998
   Morra M., 2001, WATER BIOMATERIAL SU
   Ratner BD, 2000, J BIOMAT SCI-POLYM E, V11, P1107, DOI 10.1163/156856200744219
   Schwendel D, 2001, LANGMUIR, V17, P5717, DOI 10.1021/la010576h
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Tanaka M, 2004, J BIOMED MATER RES A, V68A, P684, DOI 10.1002/jbm.a.20088
   YAMADA N, 1990, J APPL POLYM SCI, V39, P2443
NR 23
TC 2
Z9 3
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2010
VL 21
IS 14
BP 1895
EP 1910
DI 10.1163/092050610X489321
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 679HI
UT WOS:000284152100006
ER

PT J
AU Mochizuki, A
   Hatakeyama, T
   Tomono, Y
   Tanaka, M
AF Mochizuki, Akira
   Hatakeyama, Tatsuko
   Tomono, Yuka
   Tanaka, Masaru
TI Water Structure and Blood Compatibility of Poly(tetrahydrofurfuryl
   acrylate)
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Blood compatibility; water structure; differential scanning calorimetry;
   freezing bound water; poly(tetrahydrofurfuryl acrylate)
ID SELF-ASSEMBLED MONOLAYERS; COMPLEMENT ACTIVATION; PROTEIN ADSORPTION;
   POLY(2-METHOXYETHYL ACRYLATE); SURFACE; COPOLYMERS; PLASMA; PMEA
AB We previously reported that poly(2-methoxyethyl acrylate) (PMEA), which has excellent blood compatibility, contains a large amount of freezing bound water. In order to confirm the role of freezing bound water in determining blood compatibility, poly(tetrahydrofurfuryl acrylate) (PTHFA) was newly synthesized and the thermal properties of water in PTHFA were investigated by differential scanning calorimetry (DSC), as freezing bound water was observed as cold crystallization in DSC heating curves. In addition, the blood compatibility of PTHFA, including activations of platelets, the coagulation system and the complement system, was investigated. The temperature of cold crystallization of water in PTHFA was higher than that of water in PMEA; moreover, the amount of freezing bound water in PTHFA was smaller than that in PMEA. The effect of freezing bound water on blood compatibility was investigated by comparing PTHFA, PMEA, poly(2-hydroxyethyl methacrylate) (PHEMA) and poly(2-methoxyethyl methacrylate) (PMEMA). The latter two samples showed no cold crystallization. Activations of platelets, the coagulation system and the complement system were enhanced in the following order: PMEA < PHEMA < PTHFA < PMEMA, PMEA < PMEMA < PTHFA < PHEMA and PMEA < PTHFA < PMEMA < PHEMA, respectively. The above results were reasonably explained by the amount and/ or the stability of freezing bound water. (C) Koninklijke Brill NV, Leiden, 2009
C1 Tokai Univ, Dept Biomed Engn, Sch High Technol Human Welf, Shizuoka 4100395, Japan.
   Lignocel Res, Bunkyo Ku, Tokyo 1120015, Japan.
   Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan.
RP Mochizuki, A (reprint author), Tokai Univ, Dept Biomed Engn, Sch High Technol Human Welf, Nishino 317, Shizuoka 4100395, Japan.
EM azmochi@wing.ncc.u-tokai.ac.jp
CR Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   Benesch J, 2001, J BIOMAT SCI-POLYM E, V12, P581, DOI 10.1163/156856201316883421
   BERGER M, 1994, J MATER SCI-MATER M, V5, P622, DOI 10.1007/BF00120343
   CAZENAVE JP, 1986, BLOOD SURFACE INTERA
   Hansson KM, 2005, BIOMATERIALS, V26, P861, DOI 10.1016/j.biomaterials.2004.03.036
   Hirata I, 2003, J BIOMED MATER RES A, V66A, P669, DOI 10.1002/jbm.a.10067
   Hirota E, 2007, J BIOMED MATER RES A, V81A, P710, DOI 10.1002/jbm.a.31113
   JANATOVA J, 1991, COMPLEMENT INFLAMMAT, V8, P61
   Lin JC, 2000, J BIOMED MATER RES, V51, P413, DOI 10.1002/1097-4636(20000905)51:3<413::AID-JBM16>3.0.CO;2-L
   MIWA Y, 2003, J JPN SOC BIOMATER, V21, P143
   PAYNE MS, 1987, J BIOMED MATER RES, V21, P843, DOI 10.1002/jbm.820210703
   Sperling C, 2005, BIOMATERIALS, V26, P6547, DOI 10.1016/j.biomaterials.2005.04.042
   Tanaka M, 2002, BIOMACROMOLECULES, V3, P36, DOI 10.1021/bm010072y
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Tanaka M, 2000, POLYM INT, V49, P1709, DOI 10.1002/1097-0126(200012)49:12<1709::AID-PI601>3.0.CO;2-L
   Tanaka M, 2004, J BIOMED MATER RES A, V68A, P684, DOI 10.1002/jbm.a.20088
   Wolfgang G.G., 1992, ACS S SERIES, V489
NR 17
TC 10
Z9 10
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2009
VL 20
IS 5-6
BP 591
EP 603
DI 10.1163/156856209X426411
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 440NM
UT WOS:000265707000004
ER

PT J
AU Ikegami, Y
   Goto, H
   Kiyono, T
   Enomoto, M
   Kasahara, K
   Tomono, Y
   Tozawa, K
   Morita, A
   Kohri, K
   Inagaki, M
AF Ikegami, Yosuke
   Goto, Hidemasa
   Kiyono, Tohru
   Enomoto, Masato
   Kasahara, Kousuke
   Tomono, Yasuko
   Tozawa, Keiichi
   Morita, Akimichi
   Kohri, Kenjiro
   Inagaki, Masaki
TI Chk1 phosphorylation at Ser286 and Ser301 occurs with both stalled DNA
   replication and damage checkpoint stimulation
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Chk1; Cyclin-dependent kinase 2 (Cdk2); ATR; Checkpoint; Phosphorylation
ID MONOCLONAL-ANTIBODY; PATHWAYS; PROTEIN; KINASES; CANCER; CELLS; ATR
AB We previously reported Chk1 to be phosphorylated at Ser286 and Ser301 by cyclin-dependent kinase (Cdk) 1 during mitosis [T. Shiromizu et al., Genes Cells 11 (2006) 477-485]. Here, we demonstrated that Chk1-Ser-286 and -Ser301 phosphorylation also occurs in hydroxyurea (HU)-treated or ultraviolet (UV)irradiated cells. Unlike the mitosis case, however, Chk1 was phosphorylated not only at Ser286 and Ser301 but also at Ser317 and Ser345 in the checkpoint response. Treatment with Cdk inhibitors diminished Chk1 phosphorylation at Ser286 and Ser301 but not at Ser317 and Ser345 with the latter. fit vitro analyses revealed Ser286 and Ser301 oil Chk1 to serve as two major phosphorylation sites for Cdk2. Immunoprecipitation analyses further demonstrated that Ser286/Ser301 and Ser317/Ser345 phosphorylation occur in the same Chk1 molecule during the checkpoint response. In addition, Ser286/Ser301 phosphorylation by Cdk2 was observed in Chk1 Mutated to Ala at Ser317 and Ser345 (S317A/S345A), as well as Ser317/Ser345 phosphorylation by ATR was in S286A/S301A. Therefore, Chk1 phosphorylation in the checkpoint response is regulated not only by ATR but also by Cdk2. (C) 2008 Elsevier Inc. All rights reserved.
C1 Aichi Canc Ctr, Res Inst, Div Biochem, Chikusa Ku, Aichi 4648681, Japan.
   Nagoya City Univ, Grad Sch Med Sci, Dept Nephrourol, Aichi 4678601, Japan.
   Nagoya City Univ, Grad Sch Med Sci, Dept Geriatr & Environm Dermatol, Aichi 4678601, Japan.
   Natl Canc Ctr, Res Inst, Div Virol, Chuo Ku, Tokyo 1040045, Japan.
   Nagoya Univ, Grad Sch Med, Dept Cellular Oncol, Aichi 4668550, Japan.
   Shigei Med Res Inst, Div Cell & Mol Biol, Okayama 7010202, Japan.
RP Goto, H (reprint author), Aichi Canc Ctr, Res Inst, Div Biochem, Chikusa Ku, 1-1 Kanokoden, Aichi 4648681, Japan.
EM hgoto@aichi-cc.jp; minagaki@aichi-cc.jp
RI Kiyono, Tohru/H-5834-2011
FU Japan Society for the Promotion of Science; Ministry of Education,
   Science, Technology, Sports and Culture of Japan; Ministry of Health and
   Welfare, Japan; Uehara Memorial Foundation; Naito Foundation; Takeda
   Science Foundation
FX We thank K. Tsujimura (Hamamatsu University), T. Yamaguchi (Nagoya
   University), and T. Shiromizu for helpful discussions, Y. Hayashi, and
   C. Yuhara for technical assistances, and Y. Takada for secretarial
   services. This work was supported in part by Grants-in-Aid for
   Scientific Research from the Japan Society for the Promotion of Science
   and from the Ministry of Education, Science, Technology, Sports and
   Culture of Japan; by a Grant-in-Aid for the Third Term Comprehensive
   10-Year Strategy for Cancer Control from the Ministry of Health and
   Welfare, Japan; by the Uehara Memorial Foundation; by the Naito
   Foundation; and by the Takeda Science Foundation.
CR Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7
   BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110
   Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450
   Goto H, 2007, NAT PROTOC, V2, P2574, DOI 10.1038/nprot.2007.374
   Gray N, 1999, CURR MED CHEM, V6, P859
   HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079
   Jiang KC, 2003, J BIOL CHEM, V278, P25207, DOI 10.1074/jbc.M300070200
   Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097
   KISHIRO Y, 1995, CELL STRUCT FUNCT, V20, P151
   Naviaux RK, 1996, J VIROL, V70, P5701
   NISHIZAWA K, 1991, J BIOL CHEM, V266, P3074
   Rhind N, 2000, J CELL SCI, V113, P3889
   Shiromizu T, 2006, GENES CELLS, V11, P477, DOI 10.1111/j.1365-2443.2006.00955.x
   TSUJIMURA K, 1994, J BIOL CHEM, V269, P31097
   Woo Richard A, 2003, Cell Cycle, V2, P316
   YANO T, 1991, BIOCHEM BIOPH RES CO, V175, P1144, DOI 10.1016/0006-291X(91)91685-6
   Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001
   Zhou BBS, 2000, NATURE, V408, P433
NR 18
TC 6
Z9 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD DEC 26
PY 2008
VL 377
IS 4
BP 1227
EP 1231
DI 10.1016/j.bbrc.2008.10.119
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 382UM
UT WOS:000261630900039
ER

PT S
AU Kawaii, S
   Tomono, Y
   Ogawa, K
   Sugiura, M
   Yano, M
   Yoshizawa, Y
AF Kawaii, S
   Tomono, Y
   Ogawa, K
   Sugiura, M
   Yano, M
   Yoshizawa, Y
BE Shahidi, F
   Weerasinghe, DK
TI Anticancer activity and flavonoid content of various Citrus juices
SO NUTRACEUTICAL BEVERAGES: CHEMISTRY, NUTRITION, AND HEALTH EFFECTS
SE ACS SYMPOSIUM SERIES
LA English
DT Article; Proceedings Paper
CT Conference on Nutraceutical Beverages held at the 222nd National Meeting
   of the American-Chemical-Society
CY AUG 26-30, 2001
CL Chicago, IL
SP Amer Chem Soc, Div Agr & Food Chem
ID LEUKEMIA-CELLS; DIFFERENTIATION
AB It is commonly accepted that cancer formation can be prevented by the consumption of certain foods; thus flavonoids in Citrus fruits and juices are among the most prominent anticancer agents. From a viewpoint of health-promotion by dietary habits, cancer preventative activity in the Citrus juices is more important than that found in their inedible parts. However, few studies have focused on the biological activities in Citrus juices, possibly because the measurable activities in juices tend to be hindered by the more abundant substances, such as sugars. In order to eliminate the masking, we prepared the readily extractable fractions of Citrus juices by adsorbing on porous polymer resin, and successive elution from the resin with ethanol and acetone. Among 34 Citrus juices examined, King (C. nobilis) exhibited potent differentiation-inducing activity toward HL-60 leukemia cells, and the active principles were identified as four polymethoxyflavones. (C) 2004 American Chemical Society.
C1 Tokyo Denki Univ, Lab Bioorgan Chem, Hatoyama, Saitama 3500394, Japan.
   Natl Inst Fruit Tree Sci, Shimizu, Shizuoka 4240204, Japan.
   Akita Prefectural Univ, Lab Bioorgan Chem, Akita 0100195, Japan.
RP Kawaii, S (reprint author), Tokyo Denki Univ, Lab Bioorgan Chem, Hatoyama, Saitama 3500394, Japan.
CR ALBACH RF, 1969, PHYTOCHEMISTRY, V8, P127, DOI 10.1016/S0031-9422(00)85805-7
   Benavente-Garcia O., 1997, J AGR FOOD CHEM, V45, P4506
   Chen J, 1997, J AGR FOOD CHEM, V45, P364, DOI 10.1021/jf960110i
   COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458
   HANDA T, 1985, J JPN SOC HORTIC SCI, V54, P145
   Ito C, 1998, J CHIN CHEM SOC-TAIP, V45, P89
   KANES K, 1992, PHYTOCHEMISTRY, V31, P967
   Kawaii S, 1999, ANTICANCER RES, V19, P1261
   Kawaii S, 1999, J AGR FOOD CHEM, V47, P128, DOI 10.1021/jf9805101
   Kawaii S, 1999, J AGR FOOD CHEM, V47, P3565, DOI 10.1021/jf990153+
   Kawaii S, 1999, BIOSCI BIOTECH BIOCH, V63, P896, DOI 10.1271/bbb.63.896
   KOEFFLER HP, 1983, BLOOD, V62, P709
   SUGIYAMA S, 1993, CHEM PHARM BULL, V41, P714
   SWINGLE WT, CITRUS IND, V1
   TANAKA. T, 1969, Bulletin of the University of Osaka Prefecture. Series B. Agriculture and Biology, V21, P139
NR 15
TC 0
Z9 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
BN 0-8412-3823-5
J9 ACS SYM SER
PY 2004
VL 871
BP 76
EP 89
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Food
   Science & Technology
SC Biochemistry & Molecular Biology; Chemistry; Food Science & Technology
GA BY57R
UT WOS:000189412400007
ER

PT J
AU Yamada, K
   Tomono, Y
   Morimoto, J
   Sasaki, Y
   Ohmori, A
AF Yamada, K
   Tomono, Y
   Morimoto, J
   Sasaki, Y
   Ohmori, A
TI Hot corrosion behavior of boiler tube materials in refuse incineration
   environment
SO VACUUM
LA English
DT Article; Proceedings Paper
CT 3rd International Symposium on Applied Plasma Science (ISAPS 01)
CY JUL 02-06, 2001
CL FAIRBANKS, ALASKA
DE water-wall tubes; hot corrosion resistant; detonation spraying; Ni-Cr
   alloy coating; refuse incineration plant
AB Thermal spraying has emerged as an important tool of increasingly sophisticated surface engineering technology. The different functions of the coating, such as wear and corrosion resistance, thermal or electrical of insulation can be achieved using different coating techniques and coating materials. The purpose of a hot corrosion resistant coating is to serve as a effective solid-state diffusion barrier between oxygen (or other gaseous) and the base metal. The 50%Ni-50%Cr alloy coating produced by the detonation spray method exhibited the most corrosion resistance in a laboratory test. This paper presents the hot corrosion test results of the 50%Ni-50%Cr alloy spray coated boiler tubes at the actual refuse incineration plant. This plant had operated for about 7 years without any problems and the coated tubes are expected to have longer life. (C) 2002 Published by Elsevier Science Ltd.
C1 Kinki Univ, Fac Sci & Technol, Osaka 5778502, Japan.
   Tech Res Inst Hitachizosen, Osaka, Japan.
   Osaka Univ, Joining & Welding Res Inst, Osaka 5670047, Japan.
RP Morimoto, J (reprint author), Kinki Univ, Fac Sci & Technol, 3-4-1 Kowakae Higshiosaka, Osaka 5778502, Japan.
CR MORIMOTO J, 2000, P INT S HIGH TEMP CO, P275
   MORIMOTO J, 1997, J SURF FINISHING SOC, V48, P88
   MOTOKI A, 1990, JPN SOC CORROSION EN, V39, P192
   TUCKER RC, 1992, J HIGH TEMP SOC, V18, P260
   TUJINO B, 1981, J JPN THERM SPRAY SO, V18, P621
   WATANABE S, 1977, JPN I MAT, V47, P26
   YAMADA K, 1994, P 3 THERM SPRAY DIV, P6
NR 7
TC 25
Z9 27
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0042-207X
J9 VACUUM
JI Vacuum
PD MAY 27
PY 2002
VL 65
IS 3-4
BP 533
EP 540
DI 10.1016/S0042-207X(01)00468-7
PG 8
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 574CY
UT WOS:000176871900041
ER

PT J
AU Wu, PH
   Yonekura, H
   Li, H
   Nozaki, I
   Tomono, Y
   Naito, I
   Ninomiya, Y
   Yamamoto, H
AF Wu, PH
   Yonekura, H
   Li, H
   Nozaki, I
   Tomono, Y
   Naito, I
   Ninomiya, Y
   Yamamoto, H
TI Hypoxia down-regulates endostatin production by human microvascular
   endothelial cells and pericytes
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE angiostatic factor; collagen XVIII; endostatin; endothelial cell;
   hypoxia; pericyte
ID GROWTH-FACTOR; ANGIOGENESIS; INHIBITOR; ANGIOPOIETIN-2; EXPRESSION;
   AUTOCRINE; COLLAGEN; XVIII
AB Endostatin is a potent anti-angiogenic factor derived from the C-terminal region of collagen XVIII and is implicated in the regulation of physiological and pathological angiogenesis. In this study, reverse transcription-polymerase chain reaction analysis of poly(A)(+) RNA demonstrated the presence of mRNA for collagen XVIII in human endothelial cells (EC) and pericytes, the very constituents of microvessels wherein angiogenesis takes place. Enzyme immunoassay revealed that both cell types liberated endostatin into culture media and that the endostatin levels were decreased by hypoxia, the principal cause of angiogenesis. Northern and Western blot analyses revealed that while the collagen XVIII/endostatin mRNA levels were invariant between hypoxic and normoxic conditions, the collagen XVIII protein levels in EC and pericytes decreased by hypoxia. Further, exogenously administered intact endostatin was significantly decreased when it was incubated with hypoxic conditioned media of endothelial cells or pericytes, but not with normoxic media. The results suggest that the reduction of autocrine endostatin may take an active part in hypoxia-driven angiogenesis. (C) 2001 Academic Press.
C1 Kanazawa Univ, Grad Sch Med Sci, Dept Biochem & Mol Vasc Biol, Kanazawa, Ishikawa 9208640, Japan.
   Shigei Med Res Inst, Div Mol & Cell Biol, Okayama 7010202, Japan.
   Shigei Med Res Inst, Div Ultrastruct Pathol, Okayama 7010202, Japan.
   Okayama Univ, Sch Med, Dept Mol Biol & Biochem, Okayama 7008558, Japan.
RP Yamamoto, H (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Biochem & Mol Vasc Biol, Kanazawa, Ishikawa 9208640, Japan.
CR Canfield AE, 1996, J CELL SCI, V109, P343
   Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245
   GALLAGHER SR, 1995, CURRENT PROTOCOLS PR
   GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624
   Griffioen AW, 2000, PHARMACOL REV, V52, P237
   Halfter W, 1998, J BIOL CHEM, V273, P25404, DOI 10.1074/jbc.273.39.25404
   Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7
   Hiraki Y, 1997, J BIOL CHEM, V272, P32419, DOI 10.1074/jbc.272.51.32419
   KING GL, 1994, JOSLINS DIABETES MEL, P177
   Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55
   NOMURA M, 1995, J BIOL CHEM, V270, P28316
   Oh H, 1999, J BIOL CHEM, V274, P15732, DOI 10.1074/jbc.274.22.15732
   Olsen B. R., 1991, CELL BIOL EXTRACELLU, P177
   OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3
   OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6
   Saarela J, 1998, MATRIX BIOL, V16, P319, DOI 10.1016/S0945-053X(98)90003-8
   Wen W, 1999, CANCER RES, V59, P6052
   Yamagishi S, 1999, LAB INVEST, V79, P501
   YAMAGISHI S, 1993, BIOCHEM BIOPH RES CO, V190, P418, DOI 10.1006/bbrc.1993.1064
   Yonekura H, 1999, NUCLEIC ACIDS RES, V27, P2591, DOI 10.1093/nar/27.13.2591
   Yonekura H, 1999, J BIOL CHEM, V274, P35172, DOI 10.1074/jbc.274.49.35172
NR 21
TC 29
Z9 33
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD NOV 16
PY 2001
VL 288
IS 5
BP 1149
EP 1154
DI 10.1006/bbrc.2001.5903
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 497QT
UT WOS:000172467500013
ER

PT J
AU Tomono, Y
   Saito, H
   Inoue, T
AF Tomono, Y
   Saito, H
   Inoue, T
TI Effect of physical aging on the stress and birefringence relaxation
   behaviors in polycarbonate glass
SO NIHON REOROJI GAKKAISHI
LA Japanese
DT Article
DE physical aging; polycarbonate; stress relaxation; birefringence;
   enthalpy relaxation
ID AMORPHOUS POLYMERS; DISSIMILAR POLYMERS; CHAIN RELAXATION;
   VISCOELASTICITY; DEFORMATIONS; TRANSITION; DYNAMICS; VOLUME
AB The effect of physical aging on stress and birefringence relaxation behaviors in polycarbonate (PC) glass was investigated. The birefringence relaxed monotonically at the glass transition-to-rubbery plateau region for the non-aged PC, suggesting that chain orientation relaxes in a single relaxation process in this region. On the other hand, stepwise relaxation behavior was observed in birefringence for the aged PC. The birefringence relaxation curves at various temperatures for the aged PC could not be superimposed by horizontal shift. The complicated relaxation behavior could be caused not only by the physical aging but also by the rejuvenation of enthalpy during the relaxation measurement.
C1 Tokyo Inst Technol, Dept Organ & Polymer Mat, Meguro Ku, Tokyo 1528552, Japan.
RI Saito, Hiromu/C-9250-2013
OI Saito, Hiromu/0000-0002-0627-7890
CR BAUWENSCROWET C, 1991, J NON-CRYST SOLIDS, V131, P505, DOI 10.1016/0022-3093(91)90348-A
   BERENS AR, 1982, MACROMOLECULES, V15, P756, DOI 10.1021/ma00231a015
   Doi M., 1986, THEORY POLYM DYNAMIC
   Ferry J. D., 1980, VISCOELASTIC PROPERT
   HILL AJ, 1990, POLYM ENG SCI, V30, P762, DOI 10.1002/pen.760301303
   HODGE IM, 1994, J NON-CRYST SOLIDS, V169, P211, DOI 10.1016/0022-3093(94)90321-2
   HOFFMAN A, 1994, DISORDER EFFECTS REL, pCH10
   HWANG EJ, 1993, POLYMER, V34, P1661, DOI 10.1016/0032-3861(93)90325-5
   KOBAYASHI Y, 1989, MACROMOLECULES, V22, P2303
   KOENEN JA, 1989, J POLYM SCI POL PHYS, V27, P1235, DOI 10.1002/polb.1989.090270605
   KOVACS AJ, 1979, J POLYM SCI POL PHYS, V17, P1097, DOI 10.1002/pol.1979.180170701
   LIN YH, 1986, MACROMOLECULES, V19, P159, DOI 10.1021/ma00155a024
   Lin YH, 1996, MACROMOLECULES, V29, P5200, DOI 10.1021/ma9516596
   MCKENNA GB, 1991, J NON-CRYST SOLIDS, V131, P497, DOI 10.1016/0022-3093(91)90347-9
   MCKENNA GB, 1984, POLYM ENG SCI, V24, P1138, DOI 10.1002/pen.760241410
   Osaki K, 1996, MACROMOLECULES, V29, P7622, DOI 10.1021/ma9609947
   OSAKI K, 1994, J NON-CRYST SOLIDS, V172, P838, DOI 10.1016/0022-3093(94)90586-X
   PEREZ J, 1994, J NON-CRYST SOLIDS, V172, P1028, DOI 10.1016/0022-3093(94)90617-3
   READ BE, 1983, POLYM ENG SCI, V23, P835, DOI 10.1002/pen.760231509
   ROUSE PE, 1953, J CHEM PHYS, V21, P1272, DOI 10.1063/1.1699180
   SAITO H, 1991, MACROMOLECULES, V24, P6536, DOI 10.1021/ma00024a027
   SAITO H, 1992, MACROMOLECULES, V25, P1824, DOI 10.1021/ma00032a032
   SHIMO T, 1992, MACROMOLECULES, V25, P5026, DOI 10.1021/ma00045a032
   STRUIK LCE, 1978, PHYSICAL AGING AMORP
   TAKAHARA K, 1999, POLYMER, V40, pR30
   TANT MR, 1981, POLYM ENG SCI, V21, P874, DOI 10.1002/pen.760211403
   YANNAS IV, 1982, J MACROMOL SCI PHYS, VB21, P443, DOI 10.1080/00222348208018794
   Yoshida H, 1995, THERMOCHIM ACTA, V266, P119, DOI 10.1016/0040-6031(95)02437-9
NR 28
TC 3
Z9 3
PU SOC RHEOLOGY, JAPAN
PI KYOTO
PA I T E C, 3F BLDG NO.4, KYOTO RESEARCH PARK, 1, CHUDOJI-AWATA,
   SHIMOGYO-KU, KYOTO, 600, JAPAN
SN 0387-1533
J9 NIHON REOROJI GAKK
JI Nihon Reoroji Gakkaishi
PY 1999
VL 27
IS 1
BP 43
EP 48
DI 10.1678/rheology.27.43
PG 6
WC Mechanics; Polymer Science
SC Mechanics; Polymer Science
GA 190QU
UT WOS:000079976600006
ER

PT J
AU Uematsu, T
   Nagashima, S
   Niwa, M
   Kohno, K
   Sassa, T
   Ishii, M
   Tomono, Y
   Yamato, C
   Kanamaru, M
AF Uematsu, T
   Nagashima, S
   Niwa, M
   Kohno, K
   Sassa, T
   Ishii, M
   Tomono, Y
   Yamato, C
   Kanamaru, M
TI Effect of dietary fat content on oral bioavailability of menatetrenone
   in humans
SO JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
ID ABSORPTION; RATS
AB The purpose of this investigation was to determine the effects of fat content and frequency of meals on the oral bioavailability of menatetrenone (2-methyl-3-alf-trans-tetraprenyl-1,4-naphthoquinone), a vitamin K-2 with four isoprene units. in the first series of studies, menatetrenone (15 mg) was administered at breakfast time to 18 healthy male volunteers after meals with three different fat contents (meals A, B, and C) on three occasions in a crossover design. The three types of meals had almost the same calorie content (721-746 kcal) with varied fat contents (A, 8.8 g; B, 20.0 g; C, 34.9 g). The area under the plasma menatetrenone concentration-time curve within the first 24 h (AUC(0-24)) increased with increase of fat content: 371 +/- 194, 485 +/- 150, and 1024 +/- 341 ng . h/ml (mean +/- SD, n = 18) after meals A, B, and C, respectively. On the fourth occasion, the same dose of menatetrenone was administered to all volunteers after taking meal B, but in this case the lunch 5 h after drug administration was omitted from the protocol. The time profile of plasma menatetrenone showed a single peak when lunch was not taken, whereas it showed two peaks with lunch. On the fifth occasion, 12 out of 18 volunteers took the same dose of menatetrenone after a meal with the highest fat content (53.8 g of fat and 789 kcal; meal D), showing that AUC(0-24) was almost the same as that for meal C, 1027 +/- 389 and 991 +/- 392 ng . h/mL (n = 12) for meals C and D, respectively. The oral bioavailability of lipid-soluble vitamin K was influenced by the fat content of a meal, although the increase in bioavailability seemed to reach a peak when the lipid content of the meal was >35 g.
C1 GEORGETOWN UNIV,CLIN PHARMACOL CTR,WASHINGTON,DC.
   EISAI & CO LTD,DEPT CLIN PHARMACOL & BIOSTAT,DIV RES & DEV,TOKYO 11288,JAPAN.
   SHITORO CLIN,HAMAMATSU,SHIZUOKA 432,JAPAN.
RP Uematsu, T (reprint author), GIFU UNIV,SCH MED,DEPT PHARMACOL,GIFU 500,JAPAN.
CR AKIYAMA Y, 1993, JPN J PHARMACOL, V62, P145, DOI 10.1254/jjp.62.145
   BATES TR, 1980, J PHARM SCI, V64, P793
   BOUCKAERT JH, 1960, NATURE, V185, P849, DOI 10.1038/185849a0
   COLBURN WA, 1985, J CLIN PHARMACOL, V25, P583
   DEMARCO TJ, 1969, J PHARMACOL EXP THER, V169, P142
   HAUSCHKA PV, 1976, P NATL ACAD SCI USA, V73, P1447
   ISHII M, 1995, JPN PHARMACOL THER, V23, P2677
   KOSHIHARA Y, 1992, J CLIN EXP MED, V161, P439
   MARCUS R, 1990, GOODMAN GILMANS PHAR, P1564
   MURANUSHI N, 1980, INT J PHARM, V4, P271
   NAKAGAWA T, 1995, P ANN M JPN SOC PHAR, V4, P176
   ORIMO H, 1992, J BONE MINER RES, V7, pS122
   PALIN KJ, 1982, J PHARM PHARMACOL, V34, P707
   PRICE PA, 1985, VITAM HORM, V42, P65
   SHIRAKI M, 1992, SHINYAKU TO RINSHO, V41, P1249
   TADANO K, 1989, J PHARMACOBIO-DYNAM, V12, P646
   TUCKER G, 1993, LANCET, V341, P1314, DOI 10.1016/0140-6736(93)90821-W
   *MIN HLTH WEALTH J, 1993, NUTR STAT JAP PEOPL, P29
   *MIN HLTH WEALTH J, 1990, NUTR REQ JAP PEOPL V, P10
NR 19
TC 18
Z9 18
PU AMER PHARMACEUTICAL ASSN
PI WASHINGTON
PA 2215 CONSTITUTION AVE NW, WASHINGTON, DC 20037
SN 0022-3549
J9 J PHARM SCI
JI J. Pharm. Sci.
PD SEP
PY 1996
VL 85
IS 9
BP 1012
EP 1016
DI 10.1021/js9600641
PG 5
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA VF662
UT WOS:A1996VF66200020
ER

PT J
AU SUZUKI, M
   TANAKA, H
   MIURA, M
   SUZUKI, Y
   MORI, M
   TAKASAGO, M
   TOMONO, Y
AF SUZUKI, M
   TANAKA, H
   MIURA, M
   SUZUKI, Y
   MORI, M
   TAKASAGO, M
   TOMONO, Y
TI ADVANCED DIRECT SEEKING SYSTEM FOR 5.25'' MAGNETOOPTICAL DISK-DRIVE
SO JAPANESE JOURNAL OF APPLIED PHYSICS PART 1-REGULAR PAPERS SHORT NOTES &
   REVIEW PAPERS
LA English
DT Article
DE MAGNETOOPTICAL DISK DRIVE; ACCESS; DIRECT SEEK; TRACKING ERROR SIGNAL;
   LINEARIZATION; VELOCITY CONTROL; TRACK CROSS PULSE; MISCOUNT; TRACK
   COUNT
AB In order to realize high-speed access using a direct seeking system, new methods of tracking error signal transformation, relative velocity detection, and double window detection have been developed. These methods were applied to a 5.25'' magnetooptical disk drive, and a direct seeking system whose counting error is less than one track was realized.
C1 HITACHI VIDEO & INFORMAT SYST INC,TOTSUKA KU,YOKOHAMA 244,JAPAN.
   HITACHI LTD,DIV DATA STORAGE & RETRIEVAL SYST,ODAWARA 256,JAPAN.
RP SUZUKI, M (reprint author), HITACHI LTD,IMAGE & MEDIA SYST LAB,292 YOSHIDA CHO,TOTSUKA KU,YOKOHAMA 244,JAPAN.
CR ISHIBASHI H, 1987, JPN J APPL PHYS 1, V26, P167
   OGAWA M, 1991, JPN J APPL PHYS S, V30, P276
   Suzuki M., 1990, Journal of the Institute of Television Engineers of Japan, V44
   ISOIEC DIS10089 DRAF, P55
NR 4
TC 5
Z9 5
PU JAPAN J APPLIED PHYSICS
PI MINATO-KU TOKYO
PA DAINI TOYOKAIJI BLDG 24-8 SHINBASHI 4-CHOME, MINATO-KU TOKYO 105, JAPAN
SN 0021-4922
J9 JPN J APPL PHYS 1
JI Jpn. J. Appl. Phys. Part 1 - Regul. Pap. Short Notes Rev. Pap.
PD NOV
PY 1993
VL 32
IS 11B
BP 5371
EP 5375
DI 10.1143/JJAP.32.5371
PG 5
WC Physics, Applied
SC Physics
GA ML967
UT WOS:A1993ML96700037
ER

PT J
AU TOMONO, Y
   TAKAOKA, T
   YAJIMA, M
   TANOKURA, Y
   JINDA, N
AF TOMONO, Y
   TAKAOKA, T
   YAJIMA, M
   TANOKURA, Y
   JINDA, N
TI TEMPERATURE-DEPENDENCE OF LATTICE VIBRATION FREQUENCIES OF KNIF3 IN
   CONNECTION WITH ANTIFERROMAGNETISM
SO JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN
LA English
DT Article
RP TOMONO, Y (reprint author), SOPHIA UNIV,FAC SCI & TECHNOL,DEPT PHYS,CHIYODA KU,TOKYO 102,JAPAN.
CR ANDERSON PW, 1963, SOLID STATE PHYS, V14, P99
   NAKAGAWA I, 1974, APPL SPECTROSC REV, V8, P229, DOI 10.1080/05704927408060376
   SHULMAN RG, 1963, PHYS REV, V130, P506, DOI 10.1103/PhysRev.130.506
   SHULMAN RG, 1960, PHYS REV LETT, V4, P603, DOI 10.1103/PhysRevLett.4.603
   SINTANI K, 1968, J PHYS SOC JPN, V25, P99, DOI 10.1143/JPSJ.25.99
   TOMONO Y, 1984, J PHYS SOC JPN, V53, P773, DOI 10.1143/JPSJ.53.773
NR 6
TC 3
Z9 3
PU PHYSICAL SOCIETY JAPAN
PI TOKYO
PA KIKAI-SHINKO BUILDING,RM 211, 3-5-8 SHIBA-KOEN, MINATO-KU, TOKYO,
   105-0011, JAPAN
SN 0031-9015
J9 J PHYS SOC JPN
JI J. Phys. Soc. Jpn.
PD FEB
PY 1990
VL 59
IS 2
BP 579
EP 583
DI 10.1143/JPSJ.59.579
PG 5
WC Physics, Multidisciplinary
SC Physics
GA CY489
UT WOS:A1990CY48900030
ER

PT J
AU TOMONO, Y
   SATO, S
   KONDOW, T
   TANOKURA, Y
AF TOMONO, Y
   SATO, S
   KONDOW, T
   TANOKURA, Y
TI HYDROGEN ABSORPTION PROCESS BY GRAPHITE-INTERCALATION COMPOUND C24RB AT
   LIQUID-NITROGEN TEMPERATURE
SO SYNTHETIC METALS
LA English
DT Article
C1 UNIV TOKYO,DEPT CHEM,TOKYO 113,JAPAN.
RP TOMONO, Y (reprint author), SOPHIA UNIV,DEPT PHYS,TOKYO 102,JAPAN.
CR BEAUFILS JP, 1981, MOL PHYS, V44, P1257, DOI 10.1080/00268978100103171
   INOKUCHI H, 1967, J CHEM PHYS, V46, P837, DOI 10.1063/1.1840813
   KAMBE N, 1980, PHYS REV B, V21, P3491, DOI 10.1103/PhysRevB.21.3491
   KONDOW T, 1981, PHYSICS INTERCALATIO, P315
   KONDOW T, 1985, SYNTHETIC MET, V12, P213, DOI 10.1016/0379-6779(85)90112-2
   LAGRANGE P, 1972, CR HEBD ACAD SCI, V275, pC765
   WATANABE K, 1973, PROC R SOC LON SER-A, V333, P51, DOI 10.1098/rspa.1973.0047
   WATANABE K, 1971, NATURE-PHYS SCI, V233, P160
   ZABEL H, 1983, SYNTH MET, V7, P261
NR 9
TC 0
Z9 0
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE 1
PA PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND
SN 0379-6779
J9 SYNTHETIC MET
JI Synth. Met.
PD SEP 15
PY 1988
VL 25
IS 4
BP 385
EP 391
DI 10.1016/0379-6779(88)90578-4
PG 7
WC Materials Science, Multidisciplinary; Physics, Condensed Matter; Polymer
   Science
SC Materials Science; Physics; Polymer Science
GA Q2514
UT WOS:A1988Q251400008
ER

PT J
AU KONDOW, T
   SAGAWA, M
   TAKEYAMA, T
   TOMONO, Y
   ANDO, K
   MIZUTANI, U
AF KONDOW, T
   SAGAWA, M
   TAKEYAMA, T
   TOMONO, Y
   ANDO, K
   MIZUTANI, U
TI ELECTRON-SPIN-RESONANCE AND LOW-TEMPERATURE SPECIFIC-HEATS OF C24K(H2)X
   AND C24K(D2)X
SO SYNTHETIC METALS
LA English
DT Article
C1 SOPHIA UNIV,FAC SCI & ENGN,DEPT PHYS,CHIYODA KU,TOKYO 102,JAPAN.
   NAGOYA UNIV,FAC ENGN,DEPT APPL PHYS,CHIKUSA KU,NAGOYA,AICHI 464,JAPAN.
RP KONDOW, T (reprint author), UNIV TOKYO,FAC SCI,DEPT CHEM,BUNKYO KU,TOKYO 113,JAPAN.
CR DISALVO FJ, 1978, SOLID STATE COMMUN, V28, P71, DOI 10.1016/0038-1098(78)90330-7
   FEHER G, 1955, PHYS REV, V98, P337, DOI 10.1103/PhysRev.98.337
   Fowler R.H., 1940, Proceedings of the Royal Society of London, Series A (Mathematical and Physical Sciences), V174, DOI 10.1098/rspa.1940.0014
   INOKUCHI H, 1967, J CHEM PHYS, V46, P837, DOI 10.1063/1.1840813
   KONDOW T, 1981, PHYSICS INTERCALATIO, P315
   KONDOW T, 1983, SYNTHETIC MET, V6, P141, DOI 10.1016/0379-6779(83)90148-0
   LAGRANGE P, 1972, SR ACAD SCI, V275, pC765
   LOW W, 1957, PHYS REV, V105, P793, DOI 10.1103/PhysRev.105.793
   MARECHE JF, 1980, SYNTHETIC MET, V2, P267, DOI 10.1016/0379-6779(80)90056-9
   MIZUTANI U, 1978, PHYS REV B, V17, P3165, DOI 10.1103/PhysRevB.17.3165
   MURATA M, 1982, J PHYS SOC JPN, V51, P1337, DOI 10.1143/JPSJ.51.1337
   SUGIHARA K, 1984, J PHYS SOC JPN, V53, P795, DOI 10.1143/JPSJ.53.795
   SUGIHARA K, 1984, J PHYS SOC JPN, V53, P393, DOI 10.1143/JPSJ.53.393
   TERAI T, 1983, SYNTHETIC MET, V7, P49, DOI 10.1016/0379-6779(83)90083-8
   WATANABE K, 1973, PROC R SOC LON SER-A, V333, P51, DOI 10.1098/rspa.1973.0047
   WATANABE K, 1971, NATURE-PHYS SCI, V233, P160
NR 16
TC 4
Z9 4
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE 1
PA PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND
SN 0379-6779
J9 SYNTHETIC MET
JI Synth. Met.
PD NOV-DEC
PY 1985
VL 12
IS 1-2
BP 213
EP 218
DI 10.1016/0379-6779(85)90112-2
PG 6
WC Materials Science, Multidisciplinary; Physics, Condensed Matter; Polymer
   Science
SC Materials Science; Physics; Polymer Science
GA AXP03
UT WOS:A1985AXP0300036
ER

PT J
AU TOMONO, Y
   NAITO, I
   WATANABE, K
AF TOMONO, Y
   NAITO, I
   WATANABE, K
TI GLYCOSPHINGOLIPID PATTERNS OF RAT-KIDNEY DEPENDENCE ON AGE AND SEX
SO BIOCHIMICA ET BIOPHYSICA ACTA
LA English
DT Article
C1 SHIGEI MED RES INST,DIV BIOCHEM,2117 YAMADA,OKAYAMA 70102,JAPAN.
   SHIGEI MED RES INST,DIV ULTRASTRUCTURES,OKAYAMA 70102,JAPAN.
CR ADAMS EP, 1968, CHEM PHYS LIPIDS, V2, P147, DOI 10.1016/0009-3084(68)90018-2
   BARTON NW, 1975, J BIOL CHEM, V250, P8462
   BASS NH, 1981, GANGLIOSIDES NEUROBI, P29
   BOUHOURS JF, 1976, BIOCHIM BIOPHYS ACTA, V441, P123, DOI 10.1016/0005-2760(76)90287-3
   COLES L, 1970, BIOCHEM BIOPH RES CO, V38, P520, DOI 10.1016/0006-291X(70)90745-X
   COLES L, 1970, J LIPID RES, V11, P158
   COSTANTI.E, 1973, J BIOL CHEM, V248, P8240
   DUFFARD RO, 1972, BIOCHEMISTRY-US, V11, P1396, DOI 10.1021/bi00758a011
   GRAY GM, 1971, BIOCHIM BIOPHYS ACTA, V239, P494, DOI 10.1016/0005-2760(71)90041-5
   HAKOMORI S, 1976, GLYCOLIPID METHODOLO, P13
   HAKOMORI SI, 1983, HDB LIPID RES, V3, P327
   HAY JB, 1970, BIOCHIM BIOPHYS ACTA, V202, P566, DOI 10.1016/0005-2760(70)90132-3
   KANFER JN, 1983, HDB LIPID RES, V3, P437
   MARTENSS.E, 1974, J BIOL CHEM, V249, P4132
   MEISLER MH, 1978, J BIOL CHEM, V253, P3129
   MERAT A, 1973, J NEUROCHEM, V20, P873, DOI 10.1111/j.1471-4159.1973.tb00047.x
   SAITO T, 1971, J LIPID RES, V12, P257
   SIDDIQUI B, 1973, BIOCHIM BIOPHYS ACTA, V330, P147, DOI 10.1016/0005-2736(73)90219-8
   SUZUKI K, 1964, LIFE SCI, V3, P1227, DOI 10.1016/0024-3205(64)90040-2
   SVENNERHOLM L, 1963, J NEUROCHEM, V10, P613, DOI 10.1111/j.1471-4159.1963.tb08933.x
   SVENNERHOLM L, 1957, BIOCHIM BIOPHYS ACTA, V24, P604, DOI 10.1016/0006-3002(57)90254-8
   SWANK RT, 1978, RECENT PROG HORM RES, V34, P410
   SWANK RT, 1973, J MOL BIOL, V81, P225, DOI 10.1016/0022-2836(73)90191-5
   TAKI T, 1983, J BIOCHEM-TOKYO, V94, P925
   VANIER MT, 1971, J NEUROCHEM, V18, P581, DOI 10.1111/j.1471-4159.1971.tb11988.x
   WATANABE K, 1984, ANAL BIOCH
   YAMAKAWA T, 1960, J BIOCH, V48, P409
NR 27
TC 20
Z9 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0006-3002
J9 BIOCHIM BIOPHYS ACTA
PY 1984
VL 796
IS 2
BP 199
EP 204
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA TY561
UT WOS:A1984TY56100011
ER

PT J
AU TOMONO, Y
   KATO, T
   TANOKURA, Y
AF TOMONO, Y
   KATO, T
   TANOKURA, Y
TI ELECTRON-PARAMAGNETIC-RES SPECTRA FROM NI2+ PAIRS IN KZNF3 CRYSTALS
SO JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN
LA English
DT Article
RP TOMONO, Y (reprint author), SOPHIA UNIV,DEPT PHYS,CHIYODA KU,TOKYO 102,JAPAN.
CR ANDERSON PW, 1963, SOLID STATE PHYS, V14, P99
   JECK RK, 1972, PHYS REV B, V5, P1677, DOI 10.1103/PhysRevB.5.1677
   KANAMORI J, 1963, MAGNETISM, V1, P161
   MAY CEC, 1972, ELECTRON PARAMAGNETI, P427
   ORTON JW, 1960, PHYS REV LETT, V4, P128, DOI 10.1103/PhysRevLett.4.128
   SHINTANI K, 1968, J PHYS SOC JPN, V25, P99
   SHULMAN RG, 1963, PHYS REV, V130, P506, DOI 10.1103/PhysRev.130.506
   SHULMAN RG, 1960, PHYS REV LETT, V4, P603, DOI 10.1103/PhysRevLett.4.603
   TINKHAM M, 1956, PROC R SOC LON SER-A, V236, P535, DOI 10.1098/rspa.1956.0154
NR 9
TC 5
Z9 5
PU PHYSICAL SOCIETY JAPAN
PI TOKYO
PA KIKAI-SHINKO BUILDING, 3-5-8 SHIBA-KOEN, MINATO-KU, TOKYO 105, JAPAN
SN 0031-9015
J9 J PHYS SOC JPN
JI J. Phys. Soc. Jpn.
PY 1984
VL 53
IS 2
BP 773
EP 779
DI 10.1143/JPSJ.53.773
PG 7
WC Physics, Multidisciplinary
SC Physics
GA SN109
UT WOS:A1984SN10900045
ER

PT J
AU HASEGAWA, J
   TOMONO, Y
   TANAKA, M
   FUJITA, T
   SUGIYAMA, K
   HIROSE, N
AF HASEGAWA, J
   TOMONO, Y
   TANAKA, M
   FUJITA, T
   SUGIYAMA, K
   HIROSE, N
TI PHARMACOKINETIC AND BIOPHARMACEUTICAL STUDIES ON AZELASTINE
   HYDROCHLORIDE IN BEAGLE DOGS BY QUANTITATIVE SELECTED-ION MONITORING
SO ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH
LA English
DT Article
C1 EISAI CO LTD,DRUG METAB & BIOPHARMACEUT SECT,KOISHIKAWA,BUNKYO KU,TOKYO 112,JAPAN.
   EISAI CO LTD,MED CHEM SECT,TOKYO,JAPAN.
   EISAI CO LTD,TOXICOL & EXPTL BIOL RES SECT,GIFU,JAPAN.
CR AWAZU S, 1970, 2ND S DRUG MET ACT K, P87
   BOXENBAU.HG, 1974, J PHARMACOKINET BIOP, V2, P123, DOI 10.1007/BF01061504
   BURSEY JT, 1973, CHEM REV, V73, P191, DOI 10.1021/cr60283a001
   COLBURN WA, 1978, DRUG METAB DISPOS, V6, P193
   GIBALDI M, 1971, J PHARM SCI, V60, P1338, DOI 10.1002/jps.2600600909
   LENKE D, 1971, ASTA A5610
   LOO JCK, 1968, J PHARM SCI, V57, P918, DOI 10.1002/jps.2600570602
   OMAILLE ERL, 1967, J PHYSIOL-LONDON, V189, P337
   RIEGELMA.S, 1973, J PHARMACOKINET BIOP, V1, P419, DOI 10.1007/BF01059666
   ROWLAND M, 1972, J PHARM SCI, V61, P70, DOI 10.1002/jps.2600610111
   ROWLAND M, 1973, J PHARMACOKINET BIOP, V1, P123, DOI 10.1007/BF01059626
   TASAKA K, 1979, ARZNEIMITTEL-FORSCH, V29-1, P488
   TATSUMI K, 1980, JPN J PHARMACOL, V30, P37
   VATNER SF, 1970, AM J PHYSIOL, V219, P170
   ZECHEL HJ, 1981, ARZNEIMITTEL-FORSCH, V31-2, P1184
NR 15
TC 7
Z9 7
PU ECV-EDITIO CANTOR VERLAG MEDIZIN NATURWISSENSCHAFTEN
PI AULENDORF
PA BANDELSTOCKWEG 20, POSTFACH 1255, D-88322 AULENDORF, GERMANY
SN 0004-4172
J9 ARZNEIMITTEL-FORSCH
JI Arzneimittelforschung
PY 1981
VL 31-2
IS 8
BP 1215
EP 1220
PG 6
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA MB843
UT WOS:A1981MB84300009
ER

EF